Absci Corporation Profile Avatar - Palmy Investing

Absci Corporation

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of b…

Biotechnology
US, Vancouver [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Absci Corporation can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Absci Corporation can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Absci Corporation.

If you want to see a demo, head over to the financial segments of AAPL

End of ABSI's Analysis
CIK: 1672688 CUSIP: 00091E109 ISIN: US00091E1091 LEI: - UEI: -
Secondary Listings
ABSI has no secondary listings inside our databases.